- Exchange: -
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Medicis Pharmaceutical Corp
MRX:US
Acquired
More on MRX
News for Medicis Pharmaceutical Corp (MRX)
-
COMPANY NEWS
-
PRESS RELEASES
-
INDUSTRY NEWS
- Serb Galenika Says It Secures Certificate for Drug Sales in EU
- Goldman Salvages Fees With Bausch After Failed Deals
- Vanguard Touts Canadian Debt Sunk by Worst Rout Since ’08
- Valeant to Raise $7.5 Billion in Debt for Bausch & Lomb Purchase
- Serbia Extends Galenika Tender to Mid-June for Valeant Unit
- Weil, Cravath, Fried Frank, Skadden: Business of Law
- Valeant Gets Funding for Bausch Deal; RCN Cable Unit Refinances
- Valeant Agrees to Buy Bausch & Lomb in $8.7 Billion Deal
- Valeant Agrees to Buy Bausch & Lomb in $8.7 Billion Deal
- Canada Stocks Rise After Valeant Buys Bausch & Lomb
- Valeant Said to Be Near to Acquiring Bausch & Lomb
- Valeant to Borrow About $7 Billion for Bausch & Lomb Buyout
- Canadian Stocks Rise as Valeant Jump Offsets Slumps in Oil, Gold
- Kasowitz Benson, Eversheds, Latham: Business of Law
- Actavis to Buy Warner Chilcott in Women’s Health Effort
- ModiFace Launches iPad Anti-aging Simulation App in Partnership With Medicis Aesthetics Canada Published May 30, 2013
- A first in Quebec: Valeant officially inaugurates its international headquarters in Laval Published May 21, 2013
- Almirall CEO on International Expansion, Porfolio Updated 15 minutes ago
- Almirall CEO Eyes $11.6 Billion COPD Market Smokers Fuel Updated 52 minutes ago
- Medtronic’s Infuse No Better Than Bone Graft With Risk Updated 2 hours ago
- FDA Investigating Lilly’s Zyprexa Injection After Two Die Updated 2 hours ago
- Global Power Players: In The Loop (06/14)
- The Top Ten Stocks for Tuesday, June 18
- Glaxo Gets Offer for Heart Drugs With Declining Sales
- Royalty Pharma Drops Judicial Review Request of Elan Bid
- Arnold & Porter, Skadden, Cravath, Willkie: Business of Law
- Drugmakers Opened to ‘Pay for Delay’ Suits by High Court
- The Top Ten Stocks for June 17
- J&J to Buy Aragon Pharmaceuticals for Cancer Candidate
- Investor's Eyes on Bernanke: In The Loop (6/17)
- ViroPharma Shares Rise on Report of Drug Company Interest
- Elan Investors Approve Buyback to Force Royalty Bid End
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Advertisement
Rate this Page